4.7 Article

Intranasal vaccination of hamsters with a Newcastle disease virus vector expressing the S1 subunit protects animals against SARS-CoV-2 disease

Related references

Note: Only part of the references are listed.
Article Microbiology

Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition

Allison J. Greaney et al.

Summary: Antibodies targeting the SARS-CoV-2 spike receptor-binding domain (RBD) are key in neutralizing antibody responses, and a deep mutational scanning method was used to assess the impact of all amino-acid mutations in the RBD on antibody binding with 10 human monoclonal antibodies. The study identified the clustered escape mutations in different surfaces of the RBD that correspond to structurally defined antibody epitopes, showing that even antibodies targeting the same surface can have distinct escape mutations.

CELL HOST & MICROBE (2021)

Article Biochemistry & Molecular Biology

Human SARS CoV-2 spike protein mutations

Lalitha Guruprasad

Summary: Analyzing spike protein sequences from different regions globally, this study found that out of 10333 sequences, 8155 proteins had mutations. A total of 9654 mutations were observed, with 44 mutations in the RBD region.

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2021)

Article Cell & Tissue Engineering

Neutralizing antibodies targeting SARS-CoV-2 spike protein

Shi Xiaojie et al.

Summary: Since it was first identified in Wuhan, China at the end of 2019, SARS-CoV-2 causing the worldwide pandemic has dramatically changed people's lives in multiple aspects. Efforts to curb the progression of the pandemic are urgently ongoing, with promising therapeutic antibodies being developed through various approaches. Studies have shown that neutralizing antibodies against SARS-CoV-2 are mainly targeting the RBD and some non-RBD domains, with convergent germline genes identified for effective antibodies.

STEM CELL RESEARCH (2021)

Review Immunology

Nanomaterial Delivery Systems for mRNA Vaccines

Michael D. Buschmann et al.

Summary: This review highlights the recent success of mRNA vaccines in SARS-CoV-2 clinical trials, emphasizing the crucial role of lipid nanoparticles in the delivery systems and providing an analysis of the determinants of lipid nanoparticles' performance in mRNA vaccines.

VACCINES (2021)

Article Biochemistry & Molecular Biology

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity

Wilfredo F. Garcia-Beltran et al.

Summary: New variants of SARS-CoV-2 show high resistance to vaccine neutralization, with some able to escape vaccine responses with just a few mutations, highlighting the importance of developing broadly protective measures against variants.
Article Biochemistry & Molecular Biology

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

Daming Zhou et al.

Summary: The race to develop vaccines against SARS-CoV-2 variants, such as B.1.1.7, B.1.351, and P.1, is ongoing as these variants have mutations in the spike protein, potentially leading to immune escape. A structure-function analysis of B.1.351 revealed tighter ACE2 binding and widespread evasion from monoclonal antibody neutralization, particularly driven by the E484K mutation.
News Item Medicine, General & Internal

Covid-19 will become endemic but with decreased potency over time, scientists believe

Ingrid Torjesen

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Multidisciplinary Sciences

Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein

Debra Van Egeren et al.

Summary: The spike protein receptor-binding domain is the target for many COVID-19 vaccines and preventive measures. Concerns over potential viral immune evasion due to narrow molecular focus have arisen, especially with new SARS-CoV-2 strains. Through analysis and modeling, it is predicted that mutants with mild changes can evade antibodies and develop resistance to vaccines, posing challenges for immune protection strategies.

PLOS ONE (2021)

Article Multidisciplinary Sciences

Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2

Jun-Gyu Park et al.

Summary: The study demonstrates that a Newcastle disease virus-based vectored-vaccine shows strong immunogenicity, safety, and protective efficacy in mice and hamsters. Animals vaccinated with this vaccine exhibit significantly decreased infection and pathological lesions following SARS-CoV-2 challenge, as well as reduced shedding of the virus.

ISCIENCE (2021)

Review Immunology

Viral targets for vaccines against COVID-19

Lianpan Dai et al.

Summary: The urgent need for vaccines to control the COVID-19 pandemic has led to the rapid development of multiple vaccine candidates, with some showing positive results in late-stage clinical trials. This article discusses the viral elements used in these candidates, the reasons why they are good targets for the immune system, and their implications for protective immunity. Dai and Gao highlight the importance of selecting the right viral targets in vaccine development to ensure an effective immune response and the overall safety and efficacy of the vaccine.

NATURE REVIEWS IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Alexandra C. Walls et al.

Review Immunology

SARS-CoV-2 Vaccines: Status Report

Fatima Amanat et al.

IMMUNITY (2020)

Article Multidisciplinary Sciences

Pathogenesis and transmission of SARS-CoV-2 in golden hamsters

Sin Fun Sia et al.

NATURE (2020)

Article Multidisciplinary Sciences

Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

Masaki Imai et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Review Immunology

Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions

Edem Gavor et al.

TRENDS IN IMMUNOLOGY (2020)

Article Immunology

A Scalable Topical Vectored Vaccine Candidate against SARS-CoV-2

Mohammed A. Rohaim et al.

VACCINES (2020)

Article Multidisciplinary Sciences

STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters

Robbert Boudewijns et al.

NATURE COMMUNICATIONS (2020)

Article Multidisciplinary Sciences

SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity

Lizhou Zhang et al.

NATURE COMMUNICATIONS (2020)

Review Biochemistry & Molecular Biology

A systematic review of SARS-CoV-2 vaccine candidates

Yetian Dong et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Microbiology

Near-Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Causing a COVID-19 Case in Peru

Carlos Padilla-Rojas et al.

MICROBIOLOGY RESOURCE ANNOUNCEMENTS (2020)

Article Microbiology

Newcastle disease vaccines-A solved problem or a continuous challenge?

Kiril M. Dimitrov et al.

VETERINARY MICROBIOLOGY (2017)

Article Agriculture, Multidisciplinary

Newcastle disease virus-based MERS-CoV candidate vaccine elicits high-level and lasting neutralizing antibodies in Bactrian camels

Liu Ren-qiang et al.

JOURNAL OF INTEGRATIVE AGRICULTURE (2017)

Correction Biotechnology & Applied Microbiology

Safety and Clinical Usage of Newcastle Disease Virus in Cancer Therapy (vol 2011, 718710, 2011)

Han Yuen Lam et al.

BIOMED RESEARCH INTERNATIONAL (2017)

Article Veterinary Sciences

Thermal Stability Study of Five Newcastle Disease Attenuated Vaccine Strains

Zineb Boumart et al.

AVIAN DISEASES (2016)

Article Computer Science, Artificial Intelligence

High-Speed Tracking with Kernelized Correlation Filters

Joao F. Henriques et al.

IEEE TRANSACTIONS ON PATTERN ANALYSIS AND MACHINE INTELLIGENCE (2015)

Article Biotechnology & Applied Microbiology

Molecular Epidemiology of Newcastle Disease in Mexico and the Potential Spillover of Viruses from Poultry into Wild Bird Species

Stivalis Cardenas Garcia et al.

APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2013)

Review Microbiology

The spike protein of SARS-CoV - a target for vaccine and therapeutic development

Lanying Du et al.

NATURE REVIEWS MICROBIOLOGY (2009)

Article Multidisciplinary Sciences

Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens

Joshua M. DiNapoli et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Review Virology

Coronavirus spike proteins in viral entry and pathogenesis

TM Gallagher et al.

VIROLOGY (2001)

Article Virology

Genome replication of Newcastle disease virus: involvement of the rule-of-six

BPH Peeters et al.

ARCHIVES OF VIROLOGY (2000)